GSGirish B. S

Girish B. S

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Girish B. S has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Advancements in SGLT2 inhibitors: pharmacokinetics, pharmacodynamics, and clinical efficacy with a focus on pharmacogenomics

    by Bhagya G, Namini M, Girish B S, R Srinivasan

    Sodium-glucose co-transporter 2 (SGLT2) inhibitors represent a pivotal advancement in the treatment of type 2 diabetes mellitus (T2DM), offering substantial improvements in glycemic control, cardiovascular protection, and renal outcomes. This review explores the pharmacokinetics, pharmacodynamics, and clinical efficacy of SGLT2 inhibitors, with a particular focus on pharmacogenomics and its impact on individual patient response. Bexagliflozin, a potent SGLT2 inhibitor, exhibits robust glycemic control through selective SGLT2 inhibition, while studies on luseogliflozin, ertugliflozin, tofogliflozin, and remogliflozin have further demonstrated the versatility and safety of this drug class. These inhibitors not only reduce HbA1c but also lower blood pressure, improve renal outcomes, and reduce the risk of major adverse cardiovascular events. Pharmacogenomics has revealed genetic polymorphisms that affect the metabolism and efficacy of SGLT2 inhibitors, guiding more precise therapeutic decisions. Variants in genes like SLC5A2 and CYP enzymes influence drug transport, metabolism, and response, paving the way for personalized treatment approaches. This growing understanding underscores the potential for pharmacogenomics to refine the selection of SGLT2 inhibitors for optimal efficacy and minimal side effects. Despite promising results, further research is needed to fully integrate pharmacogenomics into clinical practice. As personalized medicine continues to evolve, SGLT2 inhibitors, bolstered by pharmacogenomic insights, offer a compelling avenue for enhancing the management of T2DM, ultimately transforming patient care with a more tailored and effective approach.


  • Open Access

    Respiratory challenges in huntington\'s disease: The emergence of hydropneumothorax

    by C S Meghana, Girish B S, Nikitha B S, Roopa K, R Srinivasan

    Hydropneumothorax, an abnormal collection of fluid and air in the cavity of the pleural space, typically arises by medical interventions such as fluid aspiration or intercostal tube infections. Hydropneumothorax due to tuberculosis is an unusual presentation characterized by the respiratory symptoms such as shortness of breath, cough, fever, in addition to extra pulmonary symptoms. There has been a scanty data on patients presenting with hydropneumothorax due to tuberculosis as its occurrence is relatively rare. Here we present a case of 30-year-old Asian man with Huntington's disease arrived to emergency department with complaints of severe breathing issues, discomfort in his chest, and decreased response. During chest auscultation, a distinct Hippocratic succussion splash was observed which was likely attributed to fluid movement in the right lung. A CT scan indicated considerable fluid accumulations with mediastinal shift and fibro-atelectatic bands in the right lung for which he was diagnosed with hydropneumothorax. Followed which he was put on mechanical respiration and an intercostal drainage tube. Micrococcus were detected after a microbiological investigation. Sputum analysis, tuberculin skin test and PCR analysis revealed the presence of acid-fast bacillus. He then received anti TB drugs along with intravenous piperacillin-tazobactam, inotropic support, nebulization drugs. However, the patient eventually developed sepsis due to the wide spread of the infection.

  • Open Access

    Artificial intelligence and internet influence on drug utilization: Exploring self-medication trends in South Indian pharmacy students

    by B.S. Nikitha, K. Roopa, Shababiang L. Kynshi, Riya Singh Chauhan, B.S. Girish, R. Srinivasan


  • Open Access

    Effect of ARNI (Sacubitril/Valsartan) and SGLT2 Inhibitors (Dapagliflozin) either alone or in Combination on Heart Failure: An Exploration of Novelty

    by Girish B. S, Joel M. Johns, C. S Meghana, R. Srinivasan

    B. S Girish, Joel M. Johns, C. S Meghana and R. Srinivasan Author informationArticle notesCopyright and License informationCitations Corresponding author. Correspondence: Mr. Girish B S Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences (Formerly PES College of Pharmacy), PES University, Electronic City Campus, Bangalore-560100, Karnataka, INDIA. Email: girishsharma70268@gmail.com Received February 17, 2024; Revised March 30,


  • Open Access

    Adaptability of clinical pharmacist led interventions in the management of anemia of chronic renal disease: optimizing care

    by Girish B S, Srinivasan R, Joel M. Johns, C S Meghana

    Renal anemia is a common comorbidity in chronic kidney disease (CKD) patients, typically treated with erythropoiesis-stimulating agents (ESAs) like erythropoietin. However, both over- and under-treatment are prevalent. In 2008, the Pharmacy Council of India introduced the Pharm.D course to enhance pharmaceutical care in clinical settings. While extensive studies in other countries highlight the benefits of clinical pharmacists' interventions, Indian research on this topic is limited. This prospective randomized controlled trial included CKD patients not on dialysis, with serum creatinine levels of 2-6 mg/dL and hemoglobin (Hb) levels below 12 g/dL. Participants were divided into three subgroups based on baseline Hb levels: < 10 g/dL (Group I), 10-12 g/dL (Group II), and >12 g/dL (Group III). ESAs and iron supplements were adjusted to maintain Hb levels of 10-12 g/dL. Quality of life was assessed using the Short Form Health Survey-36 questionnaire. Out of 448 participants, those in the pharmacist intervention group showed a significant shift towards Group II by the trial's end, compared to the control group. The study demonstrated a significant improvement in quality of life and physical performance, particularly for those in Group II, indicating that maintaining Hb levels at 10-12 g/dL is optimal for Indian CKD patients. This trial exemplifies the profound impact clinical pharmacists can have on patient care, highlighting their crucial role in improving healthcare outcomes through active participation and targeted interventions in clinical settings.


  • Open Access

    Topical Minocycline Induced Bluish Black Hyperpigmentation in Acne Vulgaris Patient: The First Case Report of Topical Application

    by S N Sujaya, V S Ranganath, B S Girish, Joel M Johns, C S Meghana

    Minocycline induced hyperpigmentation is an aesthetically unsetting adverse drug event. Oral minocycline inducing hyperpigmentation is common course, keeping in line with this topical minocycline 4% was formulated. A moderately built woman diagnosed with acne was prescribed with topical minocycline 4% Gel and after 15 days of application she noticed dark patches on applied areas which progressed into macules. On examination, it was found that the topical minocycline has induced Type I (Bluish Black) Hyperpigmentation. To the best of clinician’s knowledge, the drug was withdrawn and observed over a period of month. Post-withdrawal for 30-days the skin started to regain its original tone. Regardless of the fact that the topical formulation has been designed to reduce the drug contact with the systemic circulation and to decrease the side-effects, will the formulation succeed in providing the effective and safe therapy in acne patients? Keywords: Topical Minocycline 4%, Hyperpigmentation, Type I, Bluish Black Pigmentation, Acne Vulgaris

  • Open Access

    Through Indian Eyes: A Case Series on Steroid-induced Secondary Cataract

    by B S Girish, C S Meghana, Joel M. Johns, R. Srinivasan

    Lichen planus, a chronic autoimmune dermatological disorder, often necessitates the use of topical corticosteroids for symptom management. However, this case series highlights the emergence of topical steroid-induced secondary cataracts in two patients, emphasizing a previously underrecognized complication. Both patients, females aged 36 and 43, presented with gradual vision loss in their left eyes, attributed to prolonged corticosteroid use for lichen planus and skin allergies, respectively. Ophthalmological examinations confirmed the diagnosis, leading to cataract surgeries. The pathogenesis involves complex cellular and molecular mechanisms, emphasizing the need for vigilant monitoring during corticosteroid therapy. Moreover, the lack of stringent reporting systems for adverse drug reactions in India underscores the necessity for comprehensive monitoring to mitigate economic and quality of life burdens. The study emphasizes the importance of judicious corticosteroid use, tapering regimens, and patient education to minimize complications while effectively managing dermatological conditions. This underscores the critical need for heightened awareness, surveillance, and patient-centred approaches to mitigate the risk of corticosteroid-induced secondary cataracts, ensuring optimal therapeutic outcomes and long-term ocular health.

  • Prevalence and Trend of Depression in Burn Survivors: A Single Center Cohort Study

    by V S Ranganath, Smitha Segu, B S Girish, Joel M Johns, C S Meghana

    Burn injuries are frequently disastrous catastrophes that can cause significant skin damage and frequently result in hypertrophic scarring. Recovery from burn injury includes 3 domains—medical, functional, and psychiatric. Psychological concerns affect both the quality of life and the disease recovery. This study assesses the prevalence of major depression or clinically significant symptoms of depression among patients hospitalized for acute burn injury, as well as their persistence once diagnosed. It is a prospective cohort that was studied in 1%-40% of patients with body surface area burn, where the Beck Depression Inventory was used as a depressive symptom measure. A total of 108 patients were included in the study, out of which 42 (38.8%) exhibited depressive symptoms. Type of burn did not affect the prevalence of depression, whereas total body surface area had an impact on prevalence rate. The Beck Depression Inventory score assessment during the study revealed that 8.4% of participants exhibited worsening of scores during the study period and only 3.4% showed improvement throughout the study. Patients with mild depressive symptoms at admission were likely to recover, whereas those with severe depressive symptoms were less likely to recover from the psychological state. To conclude, depression was more prevalent among burn survivors from the Indian community.


  • Open Access

    A review on the impact of analgesic use during pregnancy on stillbirth

    by Girish B S, Joel M Johns, Meghana C S, Rakshitha H R, Vineela Nekkanti

    A review on the impact of analgesic use during pregnancy on stillbirth - IJOGR- Print ISSN No: - 2394-2746 Online ISSN No:- 2394-2754 Article DOI No:- 10.18231/j.ijogr.2023.001, Indian Journal of Obstetrics and Gynecology Research-Indian J Obstet Gynecol Res